CLOV vs OSCR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CLOV

46.4
AI Score
VS
OSCR Wins

OSCR

56.0
AI Score

Investment Advisor Scores

CLOV

46score
Recommendation
HOLD

OSCR

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLOV OSCR Winner
Revenue 9.53B 1.49B OSCR
Net Income 1.04B 55.34M OSCR
Net Margin 10.9% 3.7% OSCR
Operating Income 1.09B 55.34M OSCR
ROE 50.7% 14.7% OSCR
ROA 9.3% 7.7% OSCR
Total Assets 11.23B 720.33M OSCR
Current Ratio 1.08 1.50 CLOV

Relative Price Performance (Last 90 Days)

CLOV 1M: +3.2% · 3M: +9.1% OSCR 1M: +7.7% · 3M: +16.6%

Current Technical Phase

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 54

RSI (14): 54.3 · Price: $4.72

OSCR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 53

RSI (14): 52.9 · Price: $32.87

Fundamentals Snapshot

Metric CLOV OSCR
Market Cap — —
Forward P/E 31.5 15.0
Trailing P/E — 25.9
Revenue (TTM) — —
Revenue Growth 0.6% 0.7%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.1%
EPS -0.05 1.29
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OSCR is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.